# Correction: Overview of the current use of levosimendan in France: a prospective observational cohort study

Bernard Cholley, Mirela Bojan, Benoit Guillon, Emmanuel Besnier, Mathieu Mattei, Bruno Levy, Alexandre Ouattara, Nadir Tafer, Clément Delmas, David Tonon, et al.

► To cite this version:

Bernard Cholley, Mirela Bojan, Benoit Guillon, Emmanuel Besnier, Mathieu Mattei, et al. Correction: Overview of the current use of levosimendan in France: a prospective observational cohort study. Annals of Intensive Care, 2023, 13 (1), pp.94. 10.1186/s13613-023-01193-y. inserm-05464554

HAL Id: inserm-05464554

https://inserm.hal.science/inserm-05464554v1

Submitted on 19 Jan 2026

HAL is a multi-disciplinary open access
archive for the deposit and dissemination of sci-
entific research documents, whether they are pub-
lished or not. The documents may come from
teaching and research institutions in France or
abroad, or from public or private research centers.

L'archive ouverte pluridisciplinaire HAL, est
destinée au dépôt et à la diffusion de documents
scientifiques de niveau recherche, publiés ou non,
émanant des établissements d'enseignement et de
recherche français ou étrangers, des laboratoires
publics ou privés.

<figure><img src="image_1.png" /></figure>

Distributed under a Creative Commons CC BY 4.0 - Attribution - International License
**CORRECTION**

Open Access

<figure><img src="image_2.png" /></figure>

# Correction: Overview of the current use of levosimendan in France: a prospective observational cohort study

Bernard Cholley<sup>1,2*</sup> ◐, Mirela Bojan<sup>3</sup>, Benoit Guillon<sup>4</sup>, Emmanuel Besnier<sup>5</sup>, Mathieu Mattei<sup>6</sup>, Bruno Levy<sup>7</sup>, Alexandre Ouattara<sup>8,9</sup>, Nadir Tafer<sup>8,9</sup>, Clément Delmas<sup>10</sup>, David Tonon<sup>11</sup>, Bertrand Rozec<sup>12</sup>, Jean-Luc Fellahi<sup>13</sup>, Pascal Lim<sup>14</sup>, François Labaste<sup>15</sup>, François Roubille<sup>16</sup>, Thibaut Caruba<sup>17</sup>, Philippe Mauriat<sup>8,9</sup> and for the ARCOTHOVA study group

**Correction: Annals of Intensive Care (2023) 13:69**
https://doi.org/10.1186/s13613-023-01164-3

In the original publication of the article [1], ARCOTHOVA study group Collaborators' member name Nicolas Nesseler was incorrectly written as Nicolas Nessler. The original article has been corrected.

**Author details**

<sup>1</sup>Department of Anaesthesiology and Intensive Care Medicine, Hôpital Européen Georges Pompidou, AP-HP, 75015 Paris, France. <sup>2</sup>Université Paris Cité, INSERM, UMR_S 1140 "Innovations Thérapeutiques en Hémostase", 75006 Paris, France. <sup>3</sup>Pôle Cardiopathies Congénitales, Hôpital Marie Lannelongue, Groupe Hospitalier Paris-Saint Joseph, 92350 Le Plessis-Robinson, France. <sup>4</sup>Department of Cardiology, University Hospital Besançon, Besançon, France. <sup>5</sup>Department of Anaesthesiology and Critical Care, Normandie Univ, UNIROUEN, INSERM U1096, CHU Rouen, 76000 Rouen, France. <sup>6</sup>Department of Cardiology and Cardiac Surgery, CHRU de Nancy, Hôpital de Brabois, Vandoeuvre-les Nancy, France. <sup>7</sup>CHRU Nancy, Critical Care, CHRU de Nancy, Hôpital de Brabois, Vandoeuvre-Les Nancy, France. <sup>8</sup>Department of Cardiovascular Anesthesia and Critical Care, CHU Bordeaux, CHU de Bordeaux, 33000 Bordeaux, France. <sup>9</sup>Biology of Cardiovascular Diseases, Université de Bordeaux, INSERM, U1034, 33600 Pessac, France. <sup>10</sup>Cardiology Department, Rangueil University Hospital, Toulouse, France. <sup>11</sup>Department of Anaesthesiology and Critical Care Medicine, University Hospital Timone, AP-HM, Aix-Marseille University, 13385 Marseille CEDEX 05, France. <sup>12</sup>Department of Anaesthesiology and Critical Care,

Institut du Thorax, Laennec Hospital, CHU de Nantes, and Nantes Université, CHU Nantes*, CNRS, INSERM, 44000 Nantes, France. <sup>13</sup>Department of Cardiothoracic Anaesthesiology and Critical Care, Louis Pradel University Hospital, Lyon, France. <sup>14</sup>Cardiology department, Henri-Mondor University Hospital, AP-HP, Créteil, France. <sup>15</sup>Department of Anaesthesiology and Critical Care Medicine, Rangueil University Hospital, Toulouse, France. <sup>16</sup>Cardiology Department INI-CRT PhyMedExp INSERM, CNRS CHU de Montpellier, Université de Montpellier, Montpellier, France. <sup>17</sup>Department of Pharmacy, Hôpital Européen Georges Pompidou, AP-HP, Paris, France.

Published online: 29 September 2023

**Reference**

1. Cholley B, Bojan M, Guillon B, Besnier E, Mattei M, Levy B, Ouattara A, Tafer N, Delmas C, Tonon D, Rozec B, Fellahi J-L, Lim P, Labaste F, Roubille F, Caruba T, Mauriat P, for the ARCOTHOVA study group. Overview of the current use of levosimendan in France: a prospective observational cohort study. Ann Intensive Care. 2023;13:69. https://doi.org/10.1186/s13613-023-01164-3.

**Publisher's Note**

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

The original article can be found online at https://doi.org/10.1186/s13613-023-01164-3.

<figure><img src="image_3.png" /></figure>

<footnote>*Correspondence:
Bernard Cholley
bernard.cholley@aphp.fr
Full list of author information is available at the end of the article</footnote>